真实世界数据显示,2 型糖尿病患者若增加至司美格鲁肽 2 mg 剂量,其糖化血红蛋白 (HbA1c) 低于 7% 的可能性与改用替拉帕肽的患者相当,且体重减轻超过 5% 的可能性更高。
美国新泽西州普莱恩斯伯勒和丹麦巴格斯沃思,2026年6月6日/PRNewswire/ -- 诺和诺德今日公布了针对接受每周一次1毫克司美格鲁肽治疗的2型糖尿病(T2D)成年患者的最新真实世界证据,该证据研究了剂量递增至...
该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Produk Berkaitan Artikel Ini
Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.
Soalan Lazim
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Semaglutide (Semaglutide) – Beli dalam talian Rybelsus semaglutide (Tablet Semaglutide) 7mg 100 tablet (versi Jepun) – Beli dalam talian Rybelsus semaglutide (Tablet Semaglutide) 14mg 100 tablet (versi Jepun) – Beli dalam talian Rybelsus semaglutide (Tablet Semaglutide) 3mg 100 tablet (versi Jepun) – Beli dalam talian.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.